世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および中国における抗ニューロフィラメントL抗体の市場規模、現状および見通し 2021-2027年


Global and China Anti Neurofilament L Antibody Market Size, Status and Forecast 2021-2027

ニューロフィラメントは、軸索の細胞質を支えるニューロンの細胞骨格に必要なフィラメントの一種である。ニューロフィラメントは、軸索にあるフィブリル成分sの中でも最も一般的なタイプである。 市場分析と洞... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年11月19日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

ニューロフィラメントは、軸索の細胞質を支えるニューロンの細胞骨格に必要なフィラメントの一種である。ニューロフィラメントは、軸索にあるフィブリル成分sの中でも最も一般的なタイプである。

市場分析と洞察。抗ニューロフィラメントL抗体の世界市場
抗ニューロフィラメントL抗体の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX%のCAGRで、2027年にはXX百万米ドルに達すると予測されます。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の抗ニューロフィラメントL抗体市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するために役立つ見事な試みを行っています。本レポートの購入者は、収益面での抗ニューロフィラメントL抗体の世界市場全体の規模など、検証済みの信頼できる市場予測にアクセスすることができます。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の抗ニューロフィラメントL抗体市場で永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の抗ニューロフィラメントL抗体市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。

世界の抗ニューロフィラメントL抗体の範囲と市場規模
抗ニューロフィラメントL抗体市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界の抗ニューロフィラメントL抗体市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
マウス抗ニューロフィラメントL抗体
ウサギ抗ニューロフィラメントL抗体
その他

用途別セグメント
学術・研究機関
製薬会社、バイオテクノロジー企業
その他

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
メルク
バイオレジェンド
セル・シグナリング・テクノロジー
ロックランド・イムノケミカルズ
バイオ・ラッド・ラボラトリーズ
エンコー・バイオテクノロジー


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti Neurofilament L Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mouse Anti Neurofilament L Antibody
1.2.3 Rabbit Anti Neurofilament L Antibody
1.2.4 Others
1.3 Market by Application
1.3.1 Global Anti Neurofilament L Antibody Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic and Research Institutes
1.3.3 Pharma and Biotech Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti Neurofilament L Antibody Market Perspective (2016-2027)
2.2 Anti Neurofilament L Antibody Growth Trends by Regions
2.2.1 Anti Neurofilament L Antibody Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti Neurofilament L Antibody Historic Market Share by Regions (2016-2021)
2.2.3 Anti Neurofilament L Antibody Forecasted Market Size by Regions (2022-2027)
2.3 Anti Neurofilament L Antibody Industry Dynamic
2.3.1 Anti Neurofilament L Antibody Market Trends
2.3.2 Anti Neurofilament L Antibody Market Drivers
2.3.3 Anti Neurofilament L Antibody Market Challenges
2.3.4 Anti Neurofilament L Antibody Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti Neurofilament L Antibody Players by Revenue
3.1.1 Global Top Anti Neurofilament L Antibody Players by Revenue (2016-2021)
3.1.2 Global Anti Neurofilament L Antibody Revenue Market Share by Players (2016-2021)
3.2 Global Anti Neurofilament L Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti Neurofilament L Antibody Revenue
3.4 Global Anti Neurofilament L Antibody Market Concentration Ratio
3.4.1 Global Anti Neurofilament L Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti Neurofilament L Antibody Revenue in 2020
3.5 Anti Neurofilament L Antibody Key Players Head office and Area Served
3.6 Key Players Anti Neurofilament L Antibody Product Solution and Service
3.7 Date of Enter into Anti Neurofilament L Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti Neurofilament L Antibody Breakdown Data by Type
4.1 Global Anti Neurofilament L Antibody Historic Market Size by Type (2016-2021)
4.2 Global Anti Neurofilament L Antibody Forecasted Market Size by Type (2022-2027)

5 Anti Neurofilament L Antibody Breakdown Data by Application
5.1 Global Anti Neurofilament L Antibody Historic Market Size by Application (2016-2021)
5.2 Global Anti Neurofilament L Antibody Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti Neurofilament L Antibody Market Size (2016-2027)
6.2 North America Anti Neurofilament L Antibody Market Size by Type
6.2.1 North America Anti Neurofilament L Antibody Market Size by Type (2016-2021)
6.2.2 North America Anti Neurofilament L Antibody Market Size by Type (2022-2027)
6.2.3 North America Anti Neurofilament L Antibody Market Size by Type (2016-2027)
6.3 North America Anti Neurofilament L Antibody Market Size by Application
6.3.1 North America Anti Neurofilament L Antibody Market Size by Application (2016-2021)
6.3.2 North America Anti Neurofilament L Antibody Market Size by Application (2022-2027)
6.3.3 North America Anti Neurofilament L Antibody Market Size by Application (2016-2027)
6.4 North America Anti Neurofilament L Antibody Market Size by Country
6.4.1 North America Anti Neurofilament L Antibody Market Size by Country (2016-2021)
6.4.2 North America Anti Neurofilament L Antibody Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anti Neurofilament L Antibody Market Size (2016-2027)
7.2 Europe Anti Neurofilament L Antibody Market Size by Type
7.2.1 Europe Anti Neurofilament L Antibody Market Size by Type (2016-2021)
7.2.2 Europe Anti Neurofilament L Antibody Market Size by Type (2022-2027)
7.2.3 Europe Anti Neurofilament L Antibody Market Size by Type (2016-2027)
7.3 Europe Anti Neurofilament L Antibody Market Size by Application
7.3.1 Europe Anti Neurofilament L Antibody Market Size by Application (2016-2021)
7.3.2 Europe Anti Neurofilament L Antibody Market Size by Application (2022-2027)
7.3.3 Europe Anti Neurofilament L Antibody Market Size by Application (2016-2027)
7.4 Europe Anti Neurofilament L Antibody Market Size by Country
7.4.1 Europe Anti Neurofilament L Antibody Market Size by Country (2016-2021)
7.4.2 Europe Anti Neurofilament L Antibody Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti Neurofilament L Antibody Market Size (2016-2027)
8.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type
8.2.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application
8.3.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region
8.4.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti Neurofilament L Antibody Market Size (2016-2027)
9.2 Latin America Anti Neurofilament L Antibody Market Size by Type
9.2.1 Latin America Anti Neurofilament L Antibody Market Size by Type (2016-2021)
9.2.2 Latin America Anti Neurofilament L Antibody Market Size by Type (2022-2027)
9.2.3 Latin America Anti Neurofilament L Antibody Market Size by Type (2016-2027)
9.3 Latin America Anti Neurofilament L Antibody Market Size by Application
9.3.1 Latin America Anti Neurofilament L Antibody Market Size by Application (2016-2021)
9.3.2 Latin America Anti Neurofilament L Antibody Market Size by Application (2022-2027)
9.3.3 Latin America Anti Neurofilament L Antibody Market Size by Application (2016-2027)
9.4 Latin America Anti Neurofilament L Antibody Market Size by Country
9.4.1 Latin America Anti Neurofilament L Antibody Market Size by Country (2016-2021)
9.4.2 Latin America Anti Neurofilament L Antibody Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti Neurofilament L Antibody Market Size (2016-2027)
10.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type
10.2.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application
10.3.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country
10.4.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Anti Neurofilament L Antibody Introduction
11.1.4 Merck Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.1.5 Merck Recent Development
11.2 BioLegend
11.2.1 BioLegend Company Details
11.2.2 BioLegend Business Overview
11.2.3 BioLegend Anti Neurofilament L Antibody Introduction
11.2.4 BioLegend Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.2.5 BioLegend Recent Development
11.3 Cell Signaling Technology
11.3.1 Cell Signaling Technology Company Details
11.3.2 Cell Signaling Technology Business Overview
11.3.3 Cell Signaling Technology Anti Neurofilament L Antibody Introduction
11.3.4 Cell Signaling Technology Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.3.5 Cell Signaling Technology Recent Development
11.4 Rockland Immunochemicals
11.4.1 Rockland Immunochemicals Company Details
11.4.2 Rockland Immunochemicals Business Overview
11.4.3 Rockland Immunochemicals Anti Neurofilament L Antibody Introduction
11.4.4 Rockland Immunochemicals Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.4.5 Rockland Immunochemicals Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Anti Neurofilament L Antibody Introduction
11.5.4 Bio-Rad Laboratories Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 EnCor Biotechnology
11.6.1 EnCor Biotechnology Company Details
11.6.2 EnCor Biotechnology Business Overview
11.6.3 EnCor Biotechnology Anti Neurofilament L Antibody Introduction
11.6.4 EnCor Biotechnology Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.6.5 EnCor Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Neurofilament is a type of filament that is required for the cytoskeleton of a neuron that supports the axon cytoplasm. The neurofilaments are the most common types of fibrillar component s that are available in the axon.

Market Analysis and Insights: Global Anti Neurofilament L Antibody Market
The global Anti Neurofilament L Antibody market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti Neurofilament L Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti Neurofilament L Antibody market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti Neurofilament L Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti Neurofilament L Antibody market.

Global Anti Neurofilament L Antibody Scope and Market Size
Anti Neurofilament L Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti Neurofilament L Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mouse Anti Neurofilament L Antibody
Rabbit Anti Neurofilament L Antibody
Others

Segment by Application
Academic and Research Institutes
Pharma and Biotech Companies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
BioLegend
Cell Signaling Technology
Rockland Immunochemicals
Bio-Rad Laboratories
EnCor Biotechnology



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti Neurofilament L Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mouse Anti Neurofilament L Antibody
1.2.3 Rabbit Anti Neurofilament L Antibody
1.2.4 Others
1.3 Market by Application
1.3.1 Global Anti Neurofilament L Antibody Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic and Research Institutes
1.3.3 Pharma and Biotech Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti Neurofilament L Antibody Market Perspective (2016-2027)
2.2 Anti Neurofilament L Antibody Growth Trends by Regions
2.2.1 Anti Neurofilament L Antibody Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti Neurofilament L Antibody Historic Market Share by Regions (2016-2021)
2.2.3 Anti Neurofilament L Antibody Forecasted Market Size by Regions (2022-2027)
2.3 Anti Neurofilament L Antibody Industry Dynamic
2.3.1 Anti Neurofilament L Antibody Market Trends
2.3.2 Anti Neurofilament L Antibody Market Drivers
2.3.3 Anti Neurofilament L Antibody Market Challenges
2.3.4 Anti Neurofilament L Antibody Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti Neurofilament L Antibody Players by Revenue
3.1.1 Global Top Anti Neurofilament L Antibody Players by Revenue (2016-2021)
3.1.2 Global Anti Neurofilament L Antibody Revenue Market Share by Players (2016-2021)
3.2 Global Anti Neurofilament L Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti Neurofilament L Antibody Revenue
3.4 Global Anti Neurofilament L Antibody Market Concentration Ratio
3.4.1 Global Anti Neurofilament L Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti Neurofilament L Antibody Revenue in 2020
3.5 Anti Neurofilament L Antibody Key Players Head office and Area Served
3.6 Key Players Anti Neurofilament L Antibody Product Solution and Service
3.7 Date of Enter into Anti Neurofilament L Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti Neurofilament L Antibody Breakdown Data by Type
4.1 Global Anti Neurofilament L Antibody Historic Market Size by Type (2016-2021)
4.2 Global Anti Neurofilament L Antibody Forecasted Market Size by Type (2022-2027)

5 Anti Neurofilament L Antibody Breakdown Data by Application
5.1 Global Anti Neurofilament L Antibody Historic Market Size by Application (2016-2021)
5.2 Global Anti Neurofilament L Antibody Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti Neurofilament L Antibody Market Size (2016-2027)
6.2 North America Anti Neurofilament L Antibody Market Size by Type
6.2.1 North America Anti Neurofilament L Antibody Market Size by Type (2016-2021)
6.2.2 North America Anti Neurofilament L Antibody Market Size by Type (2022-2027)
6.2.3 North America Anti Neurofilament L Antibody Market Size by Type (2016-2027)
6.3 North America Anti Neurofilament L Antibody Market Size by Application
6.3.1 North America Anti Neurofilament L Antibody Market Size by Application (2016-2021)
6.3.2 North America Anti Neurofilament L Antibody Market Size by Application (2022-2027)
6.3.3 North America Anti Neurofilament L Antibody Market Size by Application (2016-2027)
6.4 North America Anti Neurofilament L Antibody Market Size by Country
6.4.1 North America Anti Neurofilament L Antibody Market Size by Country (2016-2021)
6.4.2 North America Anti Neurofilament L Antibody Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anti Neurofilament L Antibody Market Size (2016-2027)
7.2 Europe Anti Neurofilament L Antibody Market Size by Type
7.2.1 Europe Anti Neurofilament L Antibody Market Size by Type (2016-2021)
7.2.2 Europe Anti Neurofilament L Antibody Market Size by Type (2022-2027)
7.2.3 Europe Anti Neurofilament L Antibody Market Size by Type (2016-2027)
7.3 Europe Anti Neurofilament L Antibody Market Size by Application
7.3.1 Europe Anti Neurofilament L Antibody Market Size by Application (2016-2021)
7.3.2 Europe Anti Neurofilament L Antibody Market Size by Application (2022-2027)
7.3.3 Europe Anti Neurofilament L Antibody Market Size by Application (2016-2027)
7.4 Europe Anti Neurofilament L Antibody Market Size by Country
7.4.1 Europe Anti Neurofilament L Antibody Market Size by Country (2016-2021)
7.4.2 Europe Anti Neurofilament L Antibody Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti Neurofilament L Antibody Market Size (2016-2027)
8.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type
8.2.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application
8.3.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region
8.4.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti Neurofilament L Antibody Market Size (2016-2027)
9.2 Latin America Anti Neurofilament L Antibody Market Size by Type
9.2.1 Latin America Anti Neurofilament L Antibody Market Size by Type (2016-2021)
9.2.2 Latin America Anti Neurofilament L Antibody Market Size by Type (2022-2027)
9.2.3 Latin America Anti Neurofilament L Antibody Market Size by Type (2016-2027)
9.3 Latin America Anti Neurofilament L Antibody Market Size by Application
9.3.1 Latin America Anti Neurofilament L Antibody Market Size by Application (2016-2021)
9.3.2 Latin America Anti Neurofilament L Antibody Market Size by Application (2022-2027)
9.3.3 Latin America Anti Neurofilament L Antibody Market Size by Application (2016-2027)
9.4 Latin America Anti Neurofilament L Antibody Market Size by Country
9.4.1 Latin America Anti Neurofilament L Antibody Market Size by Country (2016-2021)
9.4.2 Latin America Anti Neurofilament L Antibody Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti Neurofilament L Antibody Market Size (2016-2027)
10.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type
10.2.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application
10.3.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country
10.4.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Anti Neurofilament L Antibody Introduction
11.1.4 Merck Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.1.5 Merck Recent Development
11.2 BioLegend
11.2.1 BioLegend Company Details
11.2.2 BioLegend Business Overview
11.2.3 BioLegend Anti Neurofilament L Antibody Introduction
11.2.4 BioLegend Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.2.5 BioLegend Recent Development
11.3 Cell Signaling Technology
11.3.1 Cell Signaling Technology Company Details
11.3.2 Cell Signaling Technology Business Overview
11.3.3 Cell Signaling Technology Anti Neurofilament L Antibody Introduction
11.3.4 Cell Signaling Technology Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.3.5 Cell Signaling Technology Recent Development
11.4 Rockland Immunochemicals
11.4.1 Rockland Immunochemicals Company Details
11.4.2 Rockland Immunochemicals Business Overview
11.4.3 Rockland Immunochemicals Anti Neurofilament L Antibody Introduction
11.4.4 Rockland Immunochemicals Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.4.5 Rockland Immunochemicals Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Anti Neurofilament L Antibody Introduction
11.5.4 Bio-Rad Laboratories Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 EnCor Biotechnology
11.6.1 EnCor Biotechnology Company Details
11.6.2 EnCor Biotechnology Business Overview
11.6.3 EnCor Biotechnology Anti Neurofilament L Antibody Introduction
11.6.4 EnCor Biotechnology Revenue in Anti Neurofilament L Antibody Business (2016-2021)
11.6.5 EnCor Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る